Project Grant 200838820047931

The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $389,653 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant will fund a 5-year research program focused on developing AI-supported biosensing and precision therapeutic technologies using DNA nanotechnology and synthetic biology. Key product and service deliverables include: Developing a...

This $851,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program aims to develop a novel research tool for high-throughput screening of gene-carrying nanoparticles. The key product being developed is a peptoid-based barcode system that will enable accurate and efficient in vivo biodistribution studies of multiple...

The Project Grant award R21EB036154, "SEMI-SIMOA: A CHIP-SCALE FLOW-BASED SINGLE-MOLECULE ASSAY AT THE POINT-OF-CARE USING SEMICONDUCTOR TECHNOLOGY", is funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The $447,304 award will support the development of a compact, integrated circuit (IC) chip-based single-molecule assay...

The National Science Foundation (NSF) awarded a $305,000 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Nanores LLC, a small business located in West Lafayette, IN. The grant supports the development of a compact, multi-color super-resolution imaging system capable of visualizing molecular structures in thick biological tissues with nanoscale precision. The project aims to incorporate advanced features...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a Spotting-Free Nano-Oscillator Array (SFNOA) technology for high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The $349,566 award to Biosensing Instrument Inc., a for-profit manufacturer of scientific instruments based in Tempe, Arizona, aims to...

Nano Pharmasolutions, Inc. received a $275,961 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant funds the development of a novel nanoformulation drug delivery platform to address challenges associated with poorly soluble drugs. The goal is to improve drug solubility and bioavailability through innovative formulation approaches. The one-year project period runs from August 1, 2021...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will fund the development and validation of a novel optical scanning probe microscope (SPM) system for high-resolution, high-sensitivity chemical imaging in biomedical applications. The $295,308 award will support Actoprobe LLC in Albuquerque, NM to create a SPM probe...

The National Science Foundation awarded a $250,000 Project Grant to the University of Pittsburgh under the Engineering federal grant program (CFDA 47.041) to develop a biosensor platform for rapidly sorting and analyzing nanoscale vesicles and viruses. The three-year award will support the design and demonstration of a waveguide-integrated graphene nano-tweezers platform that combines transparent dielectrophoretic graphene electrodes and silicon nitride photonic waveguides. By integrating...

This National Science Foundation (NSF) CAREER award under the Engineering program (CFDA 47.041) provides $242,687 to the University of Massachusetts, Amherst to develop an ultrasensitive nanopore biosensor for point-of-care testing of infectious diseases. The project aims to create a next-generation nanopore biosensor capable of highly sensitive and specific detection and quantification of multiple infectious disease biomarkers from human blood samples. Key innovations include employing...

The National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) awarded a $488,753 project grant to Georgia Tech Research Corp and the University of Wisconsin-Madison to develop a novel "Precise Area Introduction and Transfection" (PAINT) technology. This technology aims to enable highly localized, versatile, and efficient delivery of biomolecules like nucleic acids, proteins, and viruses into cells, with the goal of...